Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Amisulpride poisoning: a report on two cases

A Tracqui1, C Mutter-Schmidt, P Kintz

  • 1Institut de Médecine Légale, Faculté de Médecine de Strasbourg, France.

Human & Experimental Toxicology
|March 1, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A deadly root and the science behind it: LC-HRMS and LC-MS/MS analysis in an aconite-induced suicide.

Forensic toxicology·2025
Same author

Semaglutide and health risk: Development and validation of a LC-HRMS method for testing semaglutide in whole blood and application to real cases.

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences·2024
Same author

Bariatric surgery and changes in metformin distribution: About a fatal case.

Journal of pharmaceutical and biomedical analysis·2024
Same author

[Testing for cannabis and synthetic cannabinoids in human specimens].

Bulletin de l'Academie nationale de medecine·2020
Same author

[Relationship between vaping and smoking among 15-year-olds in high school. Results of a descriptive cross-sectional and monocentric observational study conducted in the metropolitan area of Saint-Étienne].

Revue des maladies respiratoires·2019
Same author

Control strategy for carbapenemase-producing Enterobacteriaceae in nursing homes: perspectives inspired from three outbreaks.

The Journal of hospital infection·2018
Same journal

Establishment of a rat model of bronchopulmonary dysplasia complicated with pulmonary hypertension and its potential applications.

Human & experimental toxicology·2026
Same journal

Pulmonary iron oxide (Fe<sub>3</sub>O<sub>4</sub>) nanoparticle-biomolecule interactions modified during aging and metabolic syndrome disease progression.

Human & experimental toxicology·2026
Same journal

Retraction: Carvedilol alleviates the detrimental effects of azathioprine on hepatic tissues in experimental rats: Focusing on redox system, inflammatory and apoptosis pathways.

Human & experimental toxicology·2026
Same journal

Inhibition of store-operated calcium entry mitigates lipopolysaccharide-induced hepatotoxicity via modulating inflammatory and oxidative stress responses.

Human & experimental toxicology·2026
Same journal

Stevioside inhibits colorectal cancer progression by regulating macrophage polarization.

Human & experimental toxicology·2026
Same journal

Predictive factors of severe outcome in glufosinate ammonium poisoning: A retrospective study in Vietnam.

Human & experimental toxicology·2025
See all related articles

This study details two human poisoning cases from amisulpride, a new neuroleptic. High amisulpride blood concentrations were linked to severe symptoms, including seizures and coma, and a fatality.

Area of Science:

  • Pharmacology
  • Toxicology
  • Clinical Chemistry

Background:

  • Amisulpride is a recently developed neuroleptic medication.
  • Understanding its toxicity profile in humans is crucial for clinical safety.
  • Substituted benzamides, including amisulpride, require thorough toxicological evaluation.

Observation:

  • Two cases of human amisulpride poisoning were documented.
  • Reversed-phase High-Performance Liquid Chromatography (HPLC) with diode array detection was used for drug quantification.
  • Case 1: Non-fatal overdose (3.0 g amisulpride) resulted in seizures, light coma, hyperthermia, and tachycardia, with a blood concentration of 9.63 µg/mL.
  • Case 2: A fatality was associated with amisulpride, with a measured blood concentration of 41.70 µg/mL.

Findings:

Related Experiment Videos

  • Significant amisulpride blood concentrations correlate with severe clinical manifestations.
  • The observed symptoms in Case 1 align with known neuroleptic side effects but are exacerbated by the high dosage.
  • The fatality in Case 2 suggests a potential for life-threatening toxicity at very high amisulpride levels.

Implications:

  • These findings highlight the potential dangers of amisulpride overdose.
  • Establishing safe dosage limits and recognizing early signs of toxicity are critical for healthcare providers.
  • Further research into the dose-dependent toxicity of amisulpride is warranted to inform clinical practice and patient safety guidelines.